NIH-funded research R01 grant

PrEP and heart/kidney/metabolic health: what long-term PrEP could mean for people at risk for HIV

Official title: Effects of HIV Pre-Exposure Prophylaxis (PrEP) on Cardiovascular-Kidney-Metabolic Health and Risk for Cardiovascular Disease

Funded at Kaiser Foundation Research Institute · NIH-11415212 · Data updated 2026-11-12

This study looks at how long-term HIV PrEP with common medicines might affect heart, kidney, and metabolic health in people who don’t have HIV.

More Cardiovascular Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKaiser Foundation Research Institute
NIH-funded
Lab location1 site (Oakland, UNITED STATES)
Project startSeptember 5, 2025
Project endJune 30, 2029
Funding year2026
Award (this year)$730,229
NIH project number5R01HL178400-02
Project IDNIH-11415212 on NIH RePORTER

Who could benefit from this research

Could help

Adults at risk for HIV who are using or planning to start tenofovir-based PrEP.

Less likely to help

Individuals who are not using PrEP or do not have risk factors for HIV may not directly benefit from this research.

What this research studies

Researchers will follow a diverse group of individuals using tenofovir-based PrEP to see how it impacts metabolic factors, kidney function, and cardiovascular risk over time. The project aims to gather long-term data since many PrEP users may be older and have other health issues. By linking metabolic and renal outcomes, the study hopes to inform clinical management and prevention strategies for people at risk of HIV. The findings could help doctors tailor PrEP choices and monitoring to protect heart and kidney health.

Why it matters

Potential benefit: If successful, the study could guide safer PrEP use and monitoring to reduce cardiovascular and kidney risks for people at risk of HIV.

How similar studies have gone: Prior PrEP studies provide some data, but long-term, diverse population data on CKM health is limited and this study seeks to fill that gap.

Where this research is happening

  • Kaiser Foundation Research Institute
    Oakland, United States
    Active

Researchers

  • Principal investigator: Hechter, Rulin C — Kaiser Foundation Research Institute
  • Study coordinator: Hechter, Rulin C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.